Karani Asset Management LLC Has $2.05 Million Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Karani Asset Management LLC lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 24.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,555 shares of the biopharmaceutical company’s stock after selling 3,690 shares during the quarter. Alnylam Pharmaceuticals comprises […]

Related Keywords

Michaelw Bonney , ,Nasdaq ,Karani Asset Management ,T Rowe Price Investment Management Inc ,Alnylam Pharmaceuticals ,Cantor Fitzgerald ,Blackrock Inc ,News Ratings For Alnylam Pharmaceuticals Daily ,Securities Exchange Commission ,Quarter For Alnylam Pharmaceuticals ,Alnylam Pharmaceuticals Stock Down ,Capital International Investors ,Alnylam Pharmaceuticals Company Profile ,Insider Transactions At Alnylam Pharmaceuticals ,Goldman Sachs Group ,Alnylam Pharmaceuticals Inc ,Needham Company ,Wells Fargo Company ,Vanguard Group Inc ,Free Report ,Asset Management ,Rowe Price Investment Management ,Street Corp ,International Investors ,Director Michael ,Pharmaceuticals Stock Down ,Get Free Report ,Wells Fargo ,Alnylam Pharmaceuticals Daily ,